This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Daisuke Nomi: Innovator in Pharmaceutical Chemistry
Introduction
Daisuke Nomi is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug production. His work exemplifies the intersection of science and practical application in the pharmaceutical industry.
Latest Patents
Daisuke Nomi holds a patent for a process titled "Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof." This invention provides a method for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or its salt by reacting 1-cyano-3-octylguanidine with 3,4-dichlorobenzylamine in an ester-based organic solvent. The process is notable for its ability to be conducted at low temperatures using general-purpose equipment, resulting in a high yield of the desired compound through a safe and easy method.
Career Highlights
Daisuke Nomi is associated with Otsuka Pharmaceutical Company, Limited, where he applies his expertise in pharmaceutical development. His innovative approach has contributed to advancements in drug formulation and production, enhancing the efficiency and safety of pharmaceutical processes.
Collaborations
Daisuke has collaborated with esteemed colleagues such as Yoshihiko Okaichi and Nobuhisa Fujita. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.
Conclusion
Daisuke Nomi's contributions to pharmaceutical chemistry through his patented processes highlight his role as an innovator in the field. His work not only advances drug production techniques but also exemplifies the importance of collaboration in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
